Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Favorites
Search by Category
Search by Format
Search by Speakers
Credits Offered
Search in Packages
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By

  • Management of Anemia in IBD
    Contains 6 Component(s), Includes Credits Includes a Live Web Event on 05/20/2026 at 8:00 PM (EDT)

    Management of Anemia in IBD

    CONTINUING EDUCATION (CE) LANGUAGE

    Title:                   Management of Anemia in IBD

    Date:                   May 20, 2026

    Location:             Online

     

    ACCME Accreditation Statement

    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

    ACCME provider number: 0005000

    Credit Designation Statement

    NASPGHAN designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    ABP MOC Part 2 Credits

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.5 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    Participant must complete the assessment within 30 days of the activity.

    Iron deficiency anemia is one of the most common - and often overlooked - complications of pediatric IBD, making timely diagnosis and effective treatment essential to improving patient outcomes.  Management of Anemia in IBD will bring together experts in pediatric gastroenterology and hematology for a practical, case-based discussion on current evidence, treatment options, and real-world strategies for managing IDA in children with IBD.

    Attendees will learn best practices for diagnosing and treating iron deficiency anemia in pediatric IBD, including considerations for oral versus intravenous iron supplementation, safety, efficacy, and patient-centered decision-making. The live session will highlight practical strategies for optimizing iron repletion while managing active inflammation, and expert panelists will share real-world clinical insights on common challenges in diagnosis, treatment response, and long-term management.  The webinar will also incorporate key insights from the NASPGHAN IBD Committee position paper, Anemia in Children with Inflammatory Bowel Disease, to help attendees better understand the current clinical landscape and apply evidence-based approaches to improve patient outcomes.

    Sabina Ali, MD

    Sabina Ali, MD

    Pediatric Gastroenterologist

    Medical Director, IBD Program UCSF Benioff Children’s Hospital

    Brad Pasternak, MD

    Brad Pasternak, MD

    Medical Director, Inflammatory Bowel Disease Clinic; Medical Director, Pediatric Fecal Microbiota Transplant Program

    Phoenix Children's Hospital

    Alka Goyal, MD

    Alka Goyal, MD

    Clinical Professor, Pediatric Gastroenterology, board certified in Pediatric Gastroenterology and also serves as the associate chief of clinical affairs for the Division of Pediatric Gastroenterology, Hepatology, and Nutrition

    Stanford Medicine Children's Health

    Andrew Grossman, MD

    Andrew Grossman, MD

    Andrew B. Grossman, MD, is a pediatric gastroenterologist in the Division of Gastroenterology, Hepatology and Nutrition at Children's Hospital of Philadelphia.

    He is the co-director of CHOP's Center for Pediatric Inflammatory Bowel Disease and holds the Robert N. Baldassano, MD, Endowed Chair in Pediatric Gastroenterology.

    Madhav Vissa, MD

    Madhav Vissa, MD

    Dr. Vissa is a pediatric hematologist-oncologist who specializes in inherited blood disorders, including sickle cell disease and thalassemia, in the division of pediatric hematology at UCSF Benioff Children's Hospitals.

    Thomas Walters, MBBS, M.Sc., FRACP

    Thomas Walters, MBBS, M.Sc., FRACP

    Associate Professor of Paediatrics at University of Toronto and Staff Gastroenterologist at SickKids Hospital where he is the clinical director of the Paediatric IBD programme and physician director of the GI procedure unit.

    The Hospital for Sick Children, Toronto, Ontario, Canada

  • Clinical Utility of Integrating Functional Luminal Imaging probe with Standard EGD for Comprehensive Esophageal Assessment
    Contains 6 Component(s), Includes Credits

    Clinical Utility of Integrating Functional Luminal Imaging probe with Standard EGD for Comprehensive Esophageal Assessment

    CONTINUING EDUCATION (CE) LANGUAGE

    Title:                   Clinical Utility of Integrating Functional Luminal Imaging probe with Standard EGD for Comprehensive Esophageal Assessment

    Date:                   May 6, 2026

    Location:             Online

     

    ACCME Accreditation Statement

    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

    ACCME provider number: 0005000

    Credit Designation Statement

    NASPGHAN designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    ABP MOC Part 2 Credits

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.5 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    Participant must complete the assessment within 30 days of the activity.

    Clinical Utility of Integrating Functional Luminal Imaging probe, (using impedance planimetry technology) with Standard EGD for Comprehensive Esophageal Assessment will explore the role of functional luminal imaging probe technology in pediatric gastroenterology and its growing value in the evaluation of esophageal function during endoscopy.

    Using high-resolution impedance planimetry, this technology allows for real-time assessment of the esophagus, pylorus, and anal sphincters, offering important insights into esophagogastric junction function and esophageal contractile activity. The session will review the technology’s design and system features, practical considerations for incorporating testing into routine endoscopic procedures, and key principles of data interpretation, including diameter, cross-sectional area, compliance, distensibility, and contractile response patterns.

    Through case-based discussion and a focus on pediatric-specific applications, participants will gain practical knowledge to support more accurate diagnosis, clinical decision-making, and long-term management of complex esophageal disorders in children.  Join our experts on May 6!

    Julie Khlevner, MD

    Julie Khlevner, MD (Moderator)

    Associate Professor of Pediatrics at Columbia University Medical Center,

    Director, Gastrointestinal Motility Center Director, Pediatric Gastroenterology Clinical Trials Division of Pediatric Gastroenterology, Hepatology and Nutrition, New York Presbyterian Morgan Stanley Children's Hospital

    Dhiren Patel MBBS, MD

    Dhiren Patel MBBS, MD (Moderator)

    Professor, Department of Pediatrics at Saint Louis University School of Medicine,

    Pediatric Gastroenterology, Hepatology and Nutrition Director, Neurogastroenterology and Motility Medical Director, Pediatric Colorectal and Pelvic Reconstruction Program, SSM Cardinal Glennon Children's Medical Center

    Jose Garza, MD

    Jose Garza, MD

    Medical Director Neurogastroenterology and Motility at GI Care for Kids / Childrens Healthcare of Atlanta

    Khyati Mehta, MD

    Khyati Mehta, MD

    Academic Pediatric Gastroenterologist, Loma Linda University

    Shaista Safder, MD

    Shaista Safder, MD

    Pediatric Gastroenterologist at Orlando Health

  • Bowel Sounds: Elizabeth Rand, MD - Fontan Associated Liver Disease
    Contains 4 Component(s), Includes Credits

    Bowel Sounds: Elizabeth Rand, MD - Fontan Associated Liver Disease

    In this episode of Bowel Sounds, hosts Drs. Amber Hildreth and Jennifer Lee talk to Dr. Elizabeth Rand, a pediatric gastroenterologist in the Division of Gastroenterology, Hepatology and Nutrition at Children's Hospital of Philadelphia (CHOP), Medical Director of CHOP's Liver Transplant Program, Director of the Gastroenterology Fellowship Program and Director of the Advanced Transplant Hepatology Program. We talk everything about Fontan Associated Liver Disease (FALD), from diagnosis to management and future research opportunities in the field. 

    For Canadian listeners:

    Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege....

  • Bowel Sounds: Leonel Rodriguez, MD - Why Can't My Child Burp?
    Contains 4 Component(s), Includes Credits

    Bowel Sounds: Leonel Rodriguez, MD - Why Can't My Child Burp?

    In this episode of Bowel Sounds, hosts Dr. Peter Lu and Dr. Jason Silverman talk to Dr. Leonel Rodriguez, Chief of Pediatric Gastroenterology and Professor of Pediatrics at Yale Medicine. We discuss the rising number of children presenting to us with the inability to belch and the relatively new diagnosis of retrograde cricopharyngeal dysfunction (R-CPD).

    For Canadian listeners:

    Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege....

  • Bowel Sounds: Pete Duncan, MD, MPH - Oropharyngeal Dysphagia and Aspiration
    Contains 4 Component(s), Includes Credits

    Bowel Sounds: Pete Duncan, MD, MPH - Oropharyngeal Dysphagia and Aspiration

    In this episode, Dr. Jordan Whatley and Dr. Amber Hildreth talk to Dr. Pete Duncan, Pediatric Gastroenterologist at Boston Children's Hospital who specializes in Aerodigestive Medicine and leads the NASPGHAN Aerodigestive Special Interest Group. We talk about the evaluation and management of oropharyngeal dysphagia and aspiration in children and how the approach to these issues has changed over time. 

    For Canadian listeners:

    Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege....

  • ON DEMAND MASLD: What’s That Again?
    Contains 6 Component(s), Includes Credits

    ON DEMAND MASLD: What’s That Again?

    CONTINUING EDUCATION (CE) LANGUAGE

    Title:                   MASLD: What’s That Again?

    Date:                   March 18, 2026

    Location:             Online

     

    ACCME Accreditation Statement

    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

    ACCME provider number: 0005000

    Credit Designation Statement

    NASPGHAN designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    ABP MOC Part 2 Credits

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.5 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    Participant must complete the assessment within 30 days of the activity.

    Obesity is a pervasive form of malnutrition that drives the development of MASLD, now the leading cause of chronic liver disease worldwide. Emerging evidence suggests that even moderate weight loss can yield significant improvements in liver steatosis, inflammation, and fibrosis. Proper nutrition may not only support weight loss, but also directly counteract steatosis and its progression.  MASLD: What’s That Again? is an updated review of the AASLD guidance document on Pediatric MASLD. In addition, it brings a summary of the key findings from the JPGN publication, “Nutritional Treatment of Obesity & Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Children. 

    Dhiren Patel, MD

    Dhiren Patel, MD (Moderator)

    SSM Cardinal Glennon Children's Medical Center

    Rohit Kohli, MBBS, MS

    Rohit Kohli, MBBS, MS (Moderator)

    Keck School of Medicine of USC

    Alvin Chan, MD, PhD

    Alvin Chan, MD, PhD

    UCLA Center for Health Sciences

    Nikhil Pai, MD

    Nikhil Pai, MD

    Children's Hospital of Philadelphia

    Jeffrey Schwimmer, MD

    Jeffrey Schwimmer, MD

    Rady Children's Hospital, UCSD

    Stavra Xanthakos, MD, MS

    Stavra Xanthakos, MD, MS

    Cincinnati Children's Hospital Medical Center

  • MASLD: What’s That Again?
    Contains 6 Component(s), Includes Credits

    MASLD: What’s That Again?

    CONTINUING EDUCATION (CE) LANGUAGE

    Title:                   MASLD: What’s That Again?

    Date:                   March 18, 2026

    Location:             Online

     

    ACCME Accreditation Statement

    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

    ACCME provider number: 0005000

    Credit Designation Statement

    NASPGHAN designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    ABP MOC Part 2 Credits

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.5 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    Participant must complete the assessment within 30 days of the activity.

    Obesity is a pervasive form of malnutrition that drives the development of MASLD, now the leading cause of chronic liver disease worldwide. Emerging evidence suggests that even moderate weight loss can yield significant improvements in liver steatosis, inflammation, and fibrosis. Proper nutrition may not only support weight loss, but also directly counteract steatosis and its progression.  MASLD: What’s That Again? is an updated review of the AASLD guidance document on Pediatric MASLD. In addition, it brings a summary of the key findings from the JPGN publication, “Nutritional Treatment of Obesity & Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Children. 

    Dhiren Patel, MD

    Dhiren Patel, MD (Moderator)

    SSM Cardinal Glennon Children's Medical Center

    Rohit Kohli, MBBS, MS

    Rohit Kohli, MBBS, MS (Moderator)

    Keck School of Medicine of USC

    Alvin Chan, MD, PhD

    Alvin Chan, MD, PhD

    UCLA Center for Health Sciences

    Nikhil Pai, MD

    Nikhil Pai, MD

    Children's Hospital of Philadelphia

    Jeffrey Schwimmer, MD

    Jeffrey Schwimmer, MD

    Rady Children's Hospital, UCSD

    Stavra Xanthakos, MD, MS

    Stavra Xanthakos, MD, MS

    Cincinnati Children's Hospital Medical Center

  • Bowel Sounds: Saul Karpen MD, PhD - Updates in Biliary Atresia
    Contains 4 Component(s), Includes Credits

    Bowel Sounds: Saul Karpen MD, PhD - Updates in Biliary Atresia

    In this episode of Bowel Sounds, hosts Drs. Amber Hildreth and Jason Silverman talk to Dr. Saul Karpen, the inaugural chief scientific officer for the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at Virginia Commonwealth University, Richmond, Va., where he is a professor of internal medicine and adjunct professor in pediatric medicine at the VCU School of Medicine. We talk about new genetic discoveries in biliary atresia and the future goals of research on this important pediatric liver topic.

    For Canadian listeners:

    Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege....

  • ON DEMAND Emerging Therapeutic Frontiers in Pediatric IBD: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologics
    Contains 6 Component(s), Includes Credits

    ON DEMAND Emerging Therapeutic Frontiers in Pediatric IBD: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologics

    CONTINUING EDUCATION (CE) LANGUAGE

    Title:                   Emerging Therapeutic Frontiers in Pediatric IBD: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologics

    Date:                   February 25, 2026

    Location:             Online

     

    ACCME Accreditation Statement

    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

    ACCME provider number: 0005000

    Credit Designation Statement

    NASPGHAN designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    ABP MOC Part 2 Credits

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.5 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    Participant must complete the assessment within 30 days of the activity.

    As therapeutic options for pediatric inflammatory bowel disease (IBD) rapidly evolve, clinicians must stay current on the next generation of therapies that have the potential to dramatically enhance patient outcomes and quality of life.

    Emerging Therapeutic Frontiers in Pediatric IBD brings you an interactive, case-driven webinar that will delve into three groundbreaking areas transforming pediatric IBD care: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologic Medications. 

    Expert faculty will guide attendees through mechanisms of action, clinical trial outcomes, real-world evidence, and safety considerations, offering up-to-date insights that bridge cutting-edge research and everyday practice. By the end of this webinar, participants will be equipped with practical strategies to integrate these novel therapies into comprehensive treatment plans, optimize disease monitoring, and collaborate effectively with multidisciplinary teams, ultimately advancing care for children living with IBD.


    Erica Brenner, MD, MSCR

    Erica Brenner, MD, MSCR (Moderator)

    University of North Carolina School of Medicine

    Ruben Coleman, MD, PhD

    Ruben Coleman, MD, PhD (Moderator)

    Stanford Medicine

    Elizabeth Spencer, MD, MSc

    Elizabeth Spencer, MD, MSc (Moderator)

    Mount Sinai, Icahn School of Medicine, Kravis Children's Hospital

    Suzannah Bergstein, MD

    Suzannah Bergstein, MD

    Stanford Medicine

    Quentin Buck, MD

    Quentin Buck, MD

    Boston Children's Hospital

    Patricia Hughes, MD

    Patricia Hughes, MD

    Mount Sinai, Icahn School of Medicine

    Amelia Kellar, MD, MSc

    Amelia Kellar, MD, MSc

    University of Chicago

    Matthew Smyth, MD

    Matthew Smyth, MD

    BC Children's Hospital

  • Emerging Therapeutic Frontiers in Pediatric IBD: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologics
    Contains 5 Component(s), Includes Credits

    Emerging Therapeutic Frontiers in Pediatric IBD: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologics

    CONTINUING EDUCATION (CE) LANGUAGE

    Title:                   Emerging Therapeutic Frontiers in Pediatric IBD: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologics

    Date:                   February 25, 2026

    Location:             Online

     

    ACCME Accreditation Statement

    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

    ACCME provider number: 0005000

    Credit Designation Statement

    NASPGHAN designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    ABP MOC Part 2 Credits

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.5 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    Participant must complete the assessment within 30 days of the activity.

    As therapeutic options for pediatric inflammatory bowel disease (IBD) rapidly evolve, clinicians must stay current on the next generation of therapies that have the potential to dramatically enhance patient outcomes and quality of life.

    Emerging Therapeutic Frontiers in Pediatric IBD brings you an interactive, case-driven webinar that will delve into three groundbreaking areas transforming pediatric IBD care: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologic Medications. 

    Expert faculty will guide attendees through mechanisms of action, clinical trial outcomes, real-world evidence, and safety considerations, offering up-to-date insights that bridge cutting-edge research and everyday practice. By the end of this webinar, participants will be equipped with practical strategies to integrate these novel therapies into comprehensive treatment plans, optimize disease monitoring, and collaborate effectively with multidisciplinary teams, ultimately advancing care for children living with IBD.


    Erica Brenner, MD, MSCR

    Erica Brenner, MD, MSCR (Moderator)

    University of North Carolina School of Medicine

    Ruben Coleman, MD, PhD

    Ruben Coleman, MD, PhD (Moderator)

    Stanford Medicine

    Elizabeth Spencer, MD, MSc

    Elizabeth Spencer, MD, MSc (Moderator)

    Mount Sinai, Icahn School of Medicine, Kravis Children's Hospital

    Suzannah Bergstein, MD

    Suzannah Bergstein, MD

    Stanford Medicine

    Quentin Buck, MD

    Quentin Buck, MD

    Boston Children's Hospital

    Patricia Hughes, MD

    Patricia Hughes, MD

    Mount Sinai, Icahn School of Medicine

    Amelia Kellar, MD, MSc

    Amelia Kellar, MD, MSc

    University of Chicago

    Matthew Smyth, MD

    Matthew Smyth, MD

    BC Children's Hospital